A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic Lymphocytic Leukemia (CLL) - --
100 项与 Cephalon (UK) Ltd. 相关的临床结果
0 项与 Cephalon (UK) Ltd. 相关的专利(医药)
100 项与 Cephalon (UK) Ltd. 相关的药物交易
100 项与 Cephalon (UK) Ltd. 相关的转化医学